HFE mutations, hepatic iron, and fibrosis: Ethnic-specific association of NASH with C282Y but not with fibrotic severity

Hepatology

Volumn 36, Issue 1, 2002, Pages 142-149

  Chitturi, Shivakumar ^a   Weltman, Martin ^b   Farrell, Geoffrey C ^a   McDonald, David ^c   Liddle, Christopher ^a   Samarasinghe, Dev ^a   Lin, Rita ^a   Abeygunasekera, Shehan ^b   George, Jacob ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NEPEAN HOSPITAL   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNOLOGY; FEMALE; FERRITIN BLOOD LEVEL; GENDER; GENE FREQUENCY; GENE MUTATION; HEPATITIS; HETEROZYGOSITY; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IRON BLOOD LEVEL; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RISK FACTOR;

EID: 0036291809     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.33892     Document Type: Article

References (29)

1. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
2. Nonalcoholic steatohepatitis: A study of 49 patients
3. Nonalcoholic steatohepatitis: An expanded clinical entity
4. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years
5. Nonalcoholic steatohepatitis
6. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
7. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
8. Clinical and biochemical predictors of severe fibrosis in NASH
9. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity
10. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis
11. Non-alcoholic steatohepatitis and iron: Increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis
12. Hepatic iron and nonalcoholic fatty liver disease
13. NASH: Can we iron out the pathogenesis?
14. A population-based study of the clinical expression of the hemochromatosis gene
15. Hemochromatosis: Diagnosis and management
16. Non-alcoholic steatohepatitis: Impaired antipyrine metabolism and hypertriglyceridaemia may be clues to its pathogenesis
17. Hepatocyte cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
18. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
19. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions
20. Rapid diagnosis of hemochromatosis gene Cys282Tyr mutation by SSCP analysis
21. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis
22. Assessment of liver iron content in 271 patients: A reevaluation of direct and indirect methods
23. Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis?
24. Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease
25. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation
26. Heterogeneity of hemochromatosis in Italy
27. Utility of HFE genotyping in the investigation of mild isolated hyperferritinemia
28. Serum ferritin as a component of the insulin resistance syndrome